Anavex Life Sciences AVXL
NASDAQ AVXL
$2.02 -0.34 (-14.41%)
At close: Sep 30, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Operating Expenses (2016 - 2026)

Updated

Anavex Life Sciences (AVXL) recorded Operating Expenses of -$6.74 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $14.46 million a year earlier.

Analysis

Anavex Life Sciences (AVXL) Operating Expenses (2016 - 2026) Analysis & Trends

On a TTM basis, Anavex Life Sciences' Operating Expenses came in at $17.37 million as of Jun 30, 2026, down 68.3% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $51.41 million, down 2.8% from FY2024.

  • Across earlier fiscal years, Operating Expenses came in at $52.88 million in FY2024 (-5.2%), $55.76 million in FY2023 (+9.4%), $50.99 million in FY2022 (+21.4%) and $42 million in FY2021.
  • The fiscal Q3 2026 figure is the lowest quarterly Operating Expenses since fiscal Q4 2020.
  • On a year-over-year basis, Operating Expenses rose in two of the last seven quarters, with an average decline of 13.1%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 31.2% in fiscal Q1 2023, against a decline of 50.1% in fiscal Q1 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $6.48 million (Q2 2026), $6.78 million (Q1 2026) and $10.84 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Anavex Life Sciences 187.25 Mn -292.83 Mn - -6.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.74 Mn
Mar 31, 2026 6.48 Mn
Dec 31, 2025 6.78 Mn
Sep 30, 2025 10.84 Mn
Jun 30, 2025 14.46 Mn
Mar 31, 2025 12.51 Mn
Dec 31, 2024 13.59 Mn
Sep 30, 2024 14.27 Mn
Jun 30, 2024 14.60 Mn
Mar 31, 2024 12.62 Mn
Dec 31, 2023 11.38 Mn
Sep 30, 2023 12.66 Mn
Jun 30, 2023 13.53 Mn
Mar 31, 2023 14.19 Mn
Dec 31, 2022 15.38 Mn
Sep 30, 2022 15.28 Mn
Jun 30, 2022 12.46 Mn
Mar 31, 2022 11.52 Mn
Dec 31, 2021 11.72 Mn
Sep 30, 2021 12.25 Mn
API Access

Anavex Life Sciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=AVXL&period=max&api_key=YOUR_API_KEY